Quantitative in situ proteomics; a proposed pathway for quantification of immunohistochemistry at the light-microscopic level

Cell and Tissue Research

Volumn 360, Issue 1, 2015, Pages 109-120

  Taylor, Clive R ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Formalin fixed paraffin embedded tissues; Immunohistochemistry; Immunostain; Light microscopy; Quantitation; Quantitative in situ proteomics; Tissue based immunologic assay

Indexed keywords

ANIMAL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOHISTOCHEMISTRY; MICROSCOPY; PROCEDURES; PROTEOMICS; STANDARD;

ANIMALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY; PROTEOMICS; REFERENCE STANDARDS;

EID: 84939973167     PISSN: 0302766X     EISSN: 14320878     Source Type: Journal    
DOI: 10.1007/s00441-014-2089-0     Document Type: Review

References (47)

1. Allred DC, Harvey JM, Berardo M, Clark GM (1998) Prognostic and predictive fctors in breast cancer by IHC analysis. Mod Pathol 11:115–124
2. Becker KF, Taylor CR (2011) “Liquid morphology”: immunochemical analysis of proteins extracted from formalin-fixed paraffin-embedded tissues: combining proteomics with immunohistochemistry. Appl Immunohistochem Mol Morphol 19:1–9
3. Bogen SA, Sompuram SR (2004) Recent trends and advances in immunodiagnostics of solid tumors [review]. Biodrugs 18:387–398
4. Canadian Association of Pathologists-Association canadienne des pathologistes National Standards Committee, Torlakovic EE, Riddell R, Banerjee D, El-Zimaity H, Pilavdzic D, Dawe P, Magliocco A, Barnes P, Berendt R, Cook D, Gilks B, Williams G, Perez-Ordonez B, Wehrli B, Swanson PE, Otis CN, Nielsen S, Vyberg M, Butany J (2010) Canadian Association of Pathologists-Association canadienne des pathologistes National Standards Committee/Immunohistochemistry: best practice recommendations for standardization of immunohistochemistry tests. Am J Clin Pathol 133:354–365
5. Cartun RW (2014) Negative reagent controls in diagnostic immunohistochemistry: do we need them? An evidence-based recommendation for laboratories throughout the world. Appl Immunohistochem Mol Morphol 22:159–161
6. Cheng L, Bostwick DG (2011) Essentials of anatomic pathology. Humana/Springer, New York
7. College of American Pathologists (2013) Anatomic pathology checklist CAP accreditation program. College of American Pathologists, Northfield, pp 35–37
8. Conan Doyle A (1892) The adventures of Sherlock Holmes. Adventure XI. The adventure of the beryl coronet. Strand Magazine 3:511–525
9. Goldstein NS, Hewitt SM, Taylor CR, Members of Ad-Hoc Committee On Immunohistochemistry Standardization (2007) Recommendations for improved standardization of immunohistochemistry. Appl Immunohistochem Mol Morphol 15:124–133
10. Gown AM (2008) Current issues in ER and HER2 testing by IHC in breast cancer. Mod Pathol 21:S8–S15
11. Gu J, Taylor CR (2014) Practicing pathology in the era of big data and personalized medicine. Appl Immunohistochem Mol Morphol 22:1–9
12. Hammond ME, Hayes DH, Dowsett M, Allred DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS, Hayes M, Hicks DG, Lester S, Love RE, Mangu PB, McShane L, Miller K, Osborne CK, Paik S, Perlmutter J, Rhodes A, Sasano H, Schwartz JN, Sweep FC, Taube S, Torlakovic EE, Valenstein P, Viale G, Visscher D, Wheeler T, Williams RB, Wittliff JL, Wolff AC (2010) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. Arch Pathol Lab Med 134:907–922
13. Hewitt SM, Robinowitz M, Bogen SA, Gown AM, Kalra KL, Otis CN, Spaulding B, Taylor CR (2011) Quality assurance for design control and implementation of immunohistochemistry assays: approved guidelines, vol 31, 2nd edn. Clinical Lab Standards Institute, Wayne, no. 4
14. Ingram M, Tachy GB, Ward BR, Imam SA, Atkinson R, Ho H, Taylor CR (2010) Tissue engineered tumor models. Biotech Histochem 85:213–219
15. Kaur P, Ward B, Saha B, Young L, Groshen S, Techy G, Lu Y, Atkinson R, Taylor CR, Ingram M, Imam SA (2011) Human breast cancer histioid: an in vitro 3D co-culture model that mimics breast tumor tissue. J Histochem Cytochem 59:1087–1100
16. Leong AS, Leong TY (2011) Standardization in immunohistochemistry. Methods Mol Biol 724:37–68
17. Mire-Sluis A, Ritter N, Cherney B, Schmalzing D, Blümel M (2014a) Reference standards for therapeutic proteins: current regulatory and scientific best practices and remaining needs. Part 1. Bioprocess Int 12:26–36
18. Mire-Sluis A, Ritter N, Cherney B, Schmalzing D, Blümel M (2014b) Reference standards for therapeutic proteins: current regulatory and scientific best practices and remaining needs. Part 2. Bioprocess Int 12:12–38
19. Neumeister VM, Parisi F, England AM, Siddiqui S, Anagnostou V, Zarrella EM, Vassilakopolou M, Bai Y, Saylor S, Sapino A, Kluger Y, Hicks DG, Bussolati G, Kwei S, Rimm DL (2014) A tissue quality index; an intrinsic control for measurement of effects of pre-analytic variables on FFPE tissue. Lab Invest 94:467–474
20. NordiQC (2014) Nordic Immunohistochemical Quality Control. www.nordiqc.org. Accessed May 14th. 2014
21. Ploeg M van der, Duijndam WAL (1986) Matrix models: essential tools for microscopic cytochemical research. Histochemistry 84:283–300
22. Riera J, Simpson JF, Tamayo R, Battifora H (1999) Use of cultured cells as a control for quantitative immunocytochemical analysis of estrogen receptor in breast cancer: the Quicgel method. Am J Clin Pathol 111:329–335
23. Shi SR, Cote RJ, Taylor CR (2001) Antigen retrieval immunohistochemistry and molecular morphology in the year 2001. Appl Immunohistochem Mol Morphol 9:107–116
24. Sompuram SR, Vani K, Hafer LJ, Bogen SA (2006) Antibodies immunoreactive with formalin-fixed tissue antigens recognize linear protein epitopes. Am J Clin Pathol 125:82–90
25. Taylor CR (1974) The nature of Reed-Sternberg cells and other malignant “reticulum” cells. Lancet II:802–807
26. Taylor CR (1976) Immunohistological observations upon the development of reticulum cell sarcoma in the mouse. J Pathol 118:201–219
27. Taylor CR (1992) Report of the Immunohistochemistry Steering Committee of the Biological Stain Commission. Proposed format: package insert for immunohistochemistry products. Biotech Histochem 67:323–338
28. Taylor CR (2000) The total test approach to standardization of immunohistochemistry. Arch Pathol Lab Med 124:945–951
29. Taylor CR (2006) Quantifiable internal reference standards for immunohistochemistry: the measurement of quantity by weight. Appl Immunohistochem Mol Morphol 14:253–259
30. Taylor CR (2010) Focus on biospecimens: the issue is the tissue. Observations on the “NCI-NIST fitness for purpose quality assessment and standards workshop”. Appl Immunohistochem Mol Morphol 19:95–98
31. Taylor CR (2011) From microscopy to whole slide digital images: a century and a half of image analysis. Appl Immunohistochem Mol Morphol 19:491–493
32. Taylor CR (2014) Predictive biomarkers and companion diagnostics. The future of immunohistochemistry—“in situ proteomics”, or just a “stain”? Appl Immunohistochem Mol Morphol 22:555–562
33. Taylor CR, Becker KF (2011) Liquid morphology: immunochemical analysis of proteins extracted from formalin fixed paraffin embedded tissues: combining proteomics with immunohistochemistry. Appl Immunohistochem Mol Morphol 19:1–9
34. Taylor CR, Burns J (1974) The demonstration of plasma cells and other immunoglobulin containing cells in formalin-fixed, paraffin-embedded tissues using peroxidase labeled antibody. J Clin Pathol 27:14–20
35. Taylor CR, Cote RJ (2005) Immunomicroscopy: a diagnostic tool for the surgical pathologist, 3rd edn. Elsevier, Saunders, Philadelphia
36. Taylor CR, Levenson RM (2006) Quantification of immunohistochemistry-issues concerning methods, utility and semiquantitative assessment II. Histopathology 49:411–424
37. Taylor CR, Shi SR, Barr N, Wu N (2006) Techniques of immunohistochemistry: principles, pitfalls and standardization. In: Dabbs DJ (ed) Diagnostic immunohistochemistry, 2nd edn. Elsevier, Philadelphia, pp 1–42
38. Torlakovic EE, Francis G, Garratt J, Gilks B, Hyjek E, Ibrahim M, Miller R, Nielsen S, Petcu EB, Swanson PE, Taylor CR, Vyberg M, International Ad Hoc Expert Panel (2014) Standardization of negative controls in diagnostic immunohistochemistry: recommendations from the International Ad Hoc committee. Appl Immunohistochem Mol Morphol 22:241–252
39. Torlakovic EE, Nielsen S, Francis G, Garratt J, Gilks B, Goldsmith JD, Hornick JL, Hyjek E, Ibrahim M, Miller R, Petcu EB, Swanson PE, Zhou X, Taylor CR, Vyberg M (2015) Standardization of positive controls in diagnostic immunohistochemistry: recommendations from the International Ad Hoc Committee. Appl Immunohistochem Mol Morphol 23:1–18
40. UKNEQAS (2014) United Kingdom National External Quality Assessment Service. www.ukneqas.org.uk. Accessed May 14th. 2014
41. Vani K, Sompuram SR, Fitzgibbons P, Bogen SA (2008) National HER2 proficiency test results using standardized quantitative controls: characterization of laboratory failures. Arch Pathol Lab Med 132:211–216
42. Weidner N, Cote RJ, Suster S, Weiss LM (2009) Modern surgical pathology. Saunders Elsevier, Philadelphia
43. Welsh AW, Moeder CB, Kumar S, Gershkovich P, Alarid ET, Harigopal M, Haffty BG, Rimm DL (2011) Standardization of estrogen receptor measurement in breast cancer suggests false-negative results are a function of threshold intensity rather than percentage of positive cells. J Clin Oncol 29:2978–2984
44. Wilbur DC, Willis J, Mooney RA, Fallon MA, Moynes R, di Sant'Agnese PA (1992) Estrogen and progesterone receptor detection in archival formalin fixed paraffin-embedded tissue from breast carcinomas: a comparison of immunohistochemical with the dextran coated charcoal assay. Mod Pathol 5:79–88
45. Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A, McShane LM, Paik S, Pegram MD, Perez EA, Press MF, Rhodes A, Sturgeon CL, Taube SE, Tubbs R, Vance GH, van de Vijver M, Wheeler TM, Hayes DF, American Society of Clinical Oncology, College of American Pathologists (2007) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 25:118–145
46. Yaziji H, Taylor CR (2007) Begin at the beginning, with the tissue! The key message underlying the ASCO/CAP task-force guideline recommendations for HER2 testing. Appl Immunohistochem Mol Morphol 15:239–41
47. Yaziji H, Taylor C, Goldstein N, Dabbs D, Hammond E, Hewlett B, Floyd A, Barry TS, Martin A, Badve S, Baehner F, Cartun R, Eisen R, Swanson P, Hewitt S, Vyberg M, Hicks D, Members of the Standardization Ad-Hoc Consensus Committee (2008) Consensus recommendations on estrogen receptor testing in breast cancer by immunohistochemistry. Appl Immunohistochem Mol Morphol 16:513–520